In Brief
This article was originally published in The Rose Sheet
Executive Summary
FDA invites public input in preparation for the seventh meeting of national authorities under the International Cooperation on Cosmetics Regulation, while The National Toxicology Program requests information on technologies and non-animal approaches that can be used to screen compounds for potential neurotoxicity. More news in brief.
You may also be interested in...
Editorial: 'Stink!' Documentary On Fragrance Ills Presents Nothing New, Effectively
Set to launch to video-on-demand platforms Feb. 16, critically hailed documentary "Stink!" casts the fragrance industry as its central villain, pressing for full transparency in fragrance ingredient use, among other reforms to US chemicals regulation. Director/producer Jon Whelan's argument has holes and underrepresents industry, but his message is reaching a wide audience of receptive ears.
Animal Welfare Group Making “Headway” With Regulators Across Globe
A ban on cosmetic animal testing in Korea “is looking ever more likely,” and Cruelty Free International is making progress in other markets around the world, according to the organization’s Chief Executive Michelle Thew.
Valeant Builds Outside Of Dermatology With Bausch + Lomb Buy
Acquisition of Bausch + Lomb for $8.7 billion vaults Valeant Pharmaceuticals into consumer eye care and positions the firm to compete against pharma giants. Analysts see the move as representing “a good fit,” and the acquisition is not likely to be the last for Valeant, which has made M&A an integral part of its strategy.